-
-
[1] Warren S. Multiple primary malignant tumors: A survey of the literature and statistical study[J]. Am J Cancer, 1932, 16(4):779. [2] Aydiner A, Karadeniz A, Uygun K, et al. Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms[J]. Am J Clin Oncol, 2000, 23(4):364-370. doi: 10.1097/00000421-200008000-00011 [3] Gokyer A, Kostek O, Hacioglu MB, et al. Clinical features of the patient with multiple primary tumors: Single center experience[J]. North Clin Istanb, 2017, 4(1):43-51. http://cn.bing.com/academic/profile?id=e1ed750b6dd6e61c242655df711572a4&encoded=0&v=paper_preview&mkt=zh-cn [4] Vogt A, Schmid S, Heinimann K, et al. Multiple primary tumours: challenges and approaches, a review[J]. Esmo Open, 2017, 2(2): e000172. doi: 10.1136/esmoopen-2017-000172 [5] Lv M, Zhang X, Shen Y, et al. Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors [J]. Medicine(Baltimore), 2017, 96(17):e6799. http://cn.bing.com/academic/profile?id=edd3b315fff2ec4766314e9c223a628f&encoded=0&v=paper_preview&mkt=zh-cn [6] Park I, Ryu MH, Choi YH, et al. A phase Ⅱ study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS); chemotherapy followed by surgery and adjuvant S-1 chemotherapy in; potentially resectable gastric or gastroesophageal junction; adenocarcinoma[J]. Cancer Chemother Pharmacol, 2013, 72(4):815-823. doi: 10.1007/s00280-013-2257-z [7] Xiong BH, Cheng Y, Ma L, et al. An updated meta-analysis of randomized controlled trial assessing the effect of neoadjuvant chemotherapy in advanced gastric cancer[J]. Cancer Invest, 2014, 32 (6):272-284. doi: 10.3109/07357907.2014.911877 -
下载:
点击查看大图
图(6)
计量
- 文章访问数: 113
- HTML全文浏览量: 23
- PDF下载量: 3
- 被引次数: 0
